Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Telomir Pharmaceuticals, Inc. TELO

Set alert

Price alert · TELO

All alert types
0.92 USD -0.02 -2.15%

At close · Nov 2

0.92 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
0.92 × 1
Ask
0.94 × 1
0.9069 Day range 0.96
0.791 52-week range 1.58
YTD
-31.20%
1 year
-41.34%
Open
0.94
Prev close
0.9352
Mkt cap
67.42M
Vol
58.13K
Avg vol
84.88K
EPS
-1.11
P/E
0.00
Div yield
0.00%
More statistics
Low
0.9069
High
0.96
Forward P/E
0.00
Beta
0.00
Short ratio
5.77
Inst. own
6.92%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
4.61
200-d avg
5.36
1y target
12.15

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for TELO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

110.37 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.0×
FY 2021: -1489×FY 2022: -243×FY 2023: -15.9×FY 2024: -7.4×FY 2025: -4.0×
FY 2021 5y median -15.9× FY 2025
P/S 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 7.1×
FY 2021: -2493×FY 2022: -221×FY 2023: 60.3×FY 2024: 189×FY 2025: 7.1×
FY 2021 5y median 7.1× FY 2025
P/FCF -11.4×
FY 2021: -1736×FY 2022: -442×FY 2023: -53.7×FY 2024: -24.0×FY 2025: -11.4×
FY 2021 5y median -53.7× FY 2025
EV/EBITDA -3.4×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: -18.1×FY 2024: -15.3×FY 2025: -3.4×
FY 2021 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -8.8%
FY 2021: -0.1%FY 2022: -0.2%FY 2023: -1.9%FY 2024: -4.2%FY 2025: -8.8%
FY 2021 5y median -1.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -176.1%
FY 2021: 166.2%FY 2022: 91.1%FY 2023: -380.2%FY 2024: -2571.0%FY 2025: -176.1%
FY 2021 5y median -176.1% FY 2025
ROIC -165.0%
FY 2021: -380.9%FY 2022: 91.1%FY 2023: -111.4%FY 2024: -1662.3%FY 2025: -165.0%
FY 2021 5y median -165.0% FY 2025
ROA -141.8%
FY 2021: -251.1%FY 2022: -1752.8%FY 2023: -273.8%FY 2024: -1248.7%FY 2025: -141.8%
FY 2021 5y median -273.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 FY 2025
Operating Income 13.9%
FY 2021: 0.0%FY 2022: -518.4%FY 2023: -361.5%FY 2024: -210.6%FY 2025: 13.9%
FY 2021 FY 2025
EPS (diluted) 41.1%
FY 2021: 0.0%FY 2022: -512.8%FY 2023: -1427.8%FY 2024: -27.3%FY 2025: 41.1%
FY 2021 FY 2025
Free Cash Flow 27.3%
FY 2021: 0.0%FY 2022: -292.5%FY 2023: -723.6%FY 2024: -31.4%FY 2025: 27.3%
FY 2021 FY 2025

Financial Health

Current Ratio 5.1×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 1.9×FY 2025: 5.1×
FY 2021 5y median 0.3× FY 2025
Quick Ratio 5.1×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 1.9×FY 2025: 5.1×
FY 2021 5y median 0.3× FY 2025
Debt / Equity 0.1×
FY 2021: -1.4×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.0×FY 2024: 0.1×FY 2025: 0.7×
FY 2021 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: -2.4×FY 2024: 2.8×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31